Early Cancer Risk Review – £269
Spotting the signs of cancers early can be vitally important. In many instances, beginning treatment for cancer earlier than would otherwise have been the case can make all the difference. When looking at cancer screening tests, it’s important to appreciate that no screening can be 100% perfect. What some doctors call ‘false positives’ (results that are raised, but may turn out not to be serious) and ‘false negatives’ (results that appear normal but do not confirm the absence of a condition) can occur.
Who is this package suitable for?
At Bluecrest Health Screening, we want you to fully understand the benefits and limitations of any test and we have therefore developed a special package of screening tests that are most relevant for those who wish to review risks for certain cancers.
Your results report will be produced with considerable detail about each test:
- The Bluecrest Early Cancer Risk Review is a specialist package that combines the measurement of tumour markers in the blood (for cancers of the prostate and ovary) with a carefully selected range of other tests. The focus of the testing is on both the earlier diagnosis of cancer in addition to seeking to reduce the risk of developing cancer in the future.
- The service is designed to complement and supplement the routine cancer screening currently offered by the NHS in relation to breast cancer and cervical cancer. It focuses particularly on risk factors relating to the following cancers: ovary, prostate, oesophagus, stomach, bowel, kidney, bladder, leukaemia, lymphoma, liver, bone and lung.
What is included in your Early Cancer Risk Review?
Blood Tests Risks Relating to
- CA125 (women only) for Ovarian cancer
- PSA (men only) for Prostate cancer
- Haematology profile for Oesophagus, stomach, bowel, kidney, leukaemia, lymphoma, myeloma
- Liver check (AST, ALT, ALP, Gamma GT, Bilirubin) for Liver, bone health
- Kidney check (sodium, potassium, urea, creatinine, eGFR) for Kidney, bladder, prostate, lung
- H Pylori for future stomach cancer development
Non Blood Tests Risks relating to Risks that can relate to
- Lung function test & Smoking Status (an optional ‘Early CDT’ Lung Cancer blood check is also available for an additional charge of £169) for Lung cancer
- Breast cancer awareness instructions for Breast cancer
- Testicular cancer awareness instructions for Testicular cancer
- General cancer awareness advice for General prevention
How are results reported?
Your results are all detailed within an easy-to-understand report which will be sent to you in the post within 21 days of your screening. Your results will be sent to whichever address you gave when booking your appointment, so if you would rather receive them at your work please make sure you give the relevant details to the customer care advisor when you call. You are also able to access your results via a secure internet site or with the new Bluecrest mobile app for smartphones.
Where do screening take place?
Bluecrest operates the largest mobile screening network within the UK offering services at 1,742 locations across the country. This means you should be able to find a screening location no more than 10 minutes from your home or work. Screenings are held within private consulting rooms at hotels or conference centres which our customers often find much more relaxed than hospitals.
Alternatively, and depending on the arrangements made with your employer, Bluecrest staff are able to come direct to your offices and hold screenings on-site. If this option is chosen, Bluecrest will work with your employer to communicate the dates agreed to hold screenings on-site.